This is further exemplified by the positive effect of IL-1α treatment in patients with ovarian cancer (Buescher et al, 1993; Lee et al, 1993; Vadhan-Raj et al, 1994; Verschraegen et al, 1996). The gene discussed is IL1A; the disease is ovarian carcinoma.